Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; water for injections - indicated in adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction,or cardiac surgery.

Namibia - English - Namibia Medicines Regulatory Council

sandoz (sa) (pty) ltd - dobutamine hydrochloride - injectable solution - each 20ml contains dobutamine hydrochloride equivalent to dobutamine 20mg

Kenya - English - Pharmacy and Poisons Board

verve human care laboratories 15-a, pharmacity, selaqui, dehradun-248011,india - dobutamine hydrochloride usp - solution for injection - each ml contains: dobutamine hydrochloride usp… - dobutamine

Malta - English - Medicines Authority

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - dobutamine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - dobutamine hydrochloride 56.05mg equivalent to dobutamine 50 mg - concentrate for infusion - 50 mg/ml - active: dobutamine hydrochloride 56.05mg equivalent to dobutamine 50 mg excipient: ascorbic acid water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive beta-adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially non-cardiac in origin 1. acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure 2. low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. when dobutamine hydrochloride is used for this purpose, as is the case when exercise is used for stress testing, patients should be informed of the potential risks involved in the test. in addition, patients should be subjected to the same close monitoring that is mandatory in standard exercise stress tests, including continuous electrocardiographic monitoring.

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - dobutamine hydrochloride - sol. fol injection inj. - 250

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

peckforton pharmaceuticals ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml